Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.jcin.2019.05.050

Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI

..., Matias Nordaby
10
Volume: 12, Issue: 16, Pages: 1553 - 1561
Published: Aug 1, 2019
Abstract
The study sought to evaluate the effect of dabigatran dual therapy versus warfarin triple therapy across categories of renal function in the RE-DUAL PCI (Randomized Evaluation of Dual Antithrombotic Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) trial. The RE-DUAL PCI (NCT02164864) trial of patients with atrial fibrillation undergoing...
Paper Fields
Paper Details
Title
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
DOI
doi.org/10.1016/j.jcin.2019.05.050
Published Date
Aug 1, 2019
Volume
12
Issue
16
Pages
1553 - 1561
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.